메뉴 건너뛰기
.. 내서재 .. 알림
소속 기관/학교 인증
인증하면 논문, 학술자료 등을  무료로 열람할 수 있어요.
한국대학교, 누리자동차, 시립도서관 등 나의 기관을 확인해보세요
(국내 대학 90% 이상 구독 중)
로그인 회원가입 고객센터 ENG
주제분류

추천
검색

논문 기본 정보

자료유형
학위논문
저자정보

박미정 (경북대학교, 경북대학교 대학원)

지도교수
조영제
발행연도
2017
저작권
경북대학교 논문은 저작권에 의해 보호받습니다.

이용수1

표지
AI에게 요청하기
추천
검색

이 논문의 연구 히스토리 (2)

초록· 키워드

오류제보하기
In this study, the effect that reaches the inflammation of ethanol extracts from Caryopteris incana and fermented Caryopteris incana on induced to LPS with Raw 264.7 Cell was verified. To select optimum extraction condition, Caryopteris incana was extracted by several sorts of solvents and concentrations of solvents. The optimum conditions for extracting phenolic compounds were to extract using 80% ethanol. Cell cytotoxicity was identified by treating purified Caryopteris incana and fermented Caryopteris incana in Raw 264.7 cell at different concentrations (5, 10, 15, 20, 30, 40, 50 ㎍/mL). As a result, 5, 10, 15 ㎍/mL of Caryopteris incana and 10, 20, 30, 40 ㎍/mL of fermented Caryopteris incana was shown none effect on cell viability. Therefore, iNOS and COX-2 protein expression, NO and PGE2 production, and cytokine were conducted with group under concentration in which it doesn''t have an effect on the cell viability. Determining iNOS protein expression, both Caryopteris incana and fermented Caryopteris incana was showed 50% 15 ㎍/mL, 40 ㎍/mL concentration respectively. Determining COX-2 protein expression, Caryopteris incana was showed 50% 15 ㎍/mL concentration. And fermented Caryopteris incana was showed 17% 40 ㎍/mL concentration. To investigate NO production inhibiton, Caryopteris incana was showed 50% 15 ㎍/mL concentration. And fermented Caryopteris incana was showed 17% 40 ㎍/mL concentration even inhibited production level which is similar to the normal group. To identify PGE2 production inhibitory effect, Caryopteris incana and fermented Caryopteris incana was treated at respective concentration of 15 ㎍/mL, 30 ㎍/mL exhibited inhibition of PGE2 production aspects 30%. Protein expression of NO bio-synthesizing enzyme iNOS and PGE2 bio-synthesizing enzyme COX-2 was similar to the inhibitory effect. To determine of Pro-inflammatory cytokine down regulation, TNF-α, IL-1β, IL-6 was measured production expression. In the case of TNF-α, Caryopteris incana was showed 60% 15 ㎍/mL concentration. And fermented Caryopteris incana was showed 35% 40 ㎍/mL concentration. In the case of IL-6, both Caryopteris incana and fermented Caryopteris incana was showed 35% 15 ㎍/mL,40 ㎍/mL concentration respectively. In the case of IL-1β, Caryopteris incana was showed 48% 15 ㎍/mL concentration. And fermented Caryopteris incana was showed 30% 40 ㎍/mL concentration.
These results show that fermented Caryopteris incana was the more reduced cytotoxic than Caryopteris incana and both Caryopteris incana and fermented Caryopteris incana inhibits cell inflammation by decreasing the expression and secretion of inflammation inducing substances in Raw 264.7 cell induced by LPS. Therefore, it was found that both Caryopteris incana and fermented Caryopteris incana can be used as an excellent material for the development of new anti-inflammatory drugs.

목차

Ⅰ. 서론 1
Ⅱ. 재료 및 방법 5
1. 실험재료 5
2. 추출물 제조 5
3. Lactobacillus plantarum을 이용한 발효물 제조 5
3.1 Lactobacillus plantarum 배양 5
3.2 발효 ethanol 추출물 제조 6
4. Total phenolics content 측정 6
5. Raw 264.7 cell line 염증 억제 효과 측정 6
5.1 시약 및 기기 6
5.2 세포 배양 7
5.3 MTT assay에 의한 세포 독성 측정 7
5.4 Western blot을 이용한 iNOS protein 및 COX-­2 protein 발현 측정 8
5.5 Nitric oxide (NO) 측정 8
5.6 Prostaglandin E2 (PGE2) 발현 억제 효과 측정 9
5.7 Cytokine 생성량 측정 9
5.7.1 Tumor necrosis factor-­α (TNF-­α) 저해 활성 측정 9
5.7.2 Interleukin­-6 (IL-­6) 저해 활성 측정 10
5.7.3. Interleukin-­1β (IL-­1β) 저해 활성 측정 11
6. 통계처리 11
Ⅲ. 결과 및 고찰 12
1. 추출물의 제조 조건 12
1.1 추출 용매에 따른 total phenolics의 용출량 13
1.2 Ethanol 농도에 따른 total phenolics의 용출량 14
2. 비발효 ethanol 추출물과 발효 ethanol 추출물의 항염증 효과 15
2.1 Raw 264.7 cell의 생존율 확인 (MTT assay) 15
2.2 Western blot을 통한 iNOS, COX-2 단백질의 발현 억제 17
2.2.1 Inducible nitric oxide synthase (iNOS) 단백질 발현 억제 17
2.2.2 Cyclooxygenase­2 (COX-­2) 단백질 발현 억제 19
2.3 Nitric oxide (NO) 생성 억제 21
2.4 Prostaglandin E2 (PGE2) 생성 억제 23
2.5 Cytokine 저해 활성 25
2.5.1 Tumor necrosis factor-­α (TNF-­α) 저해 활성 25
2.5.2 Interleukin-­6 (IL-­6) 저해 활성 27
2.5.3 Interleukin­-1β (IL-­1β) 저해 활성 29
Ⅳ. 요약 31
Ⅴ. 참고문헌 33
Ⅵ. 영문요약 41

최근 본 자료

전체보기

댓글(0)

0